INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹1,478 Cr | ₹1,073 Cr | ₹736 Cr | ₹469 Cr | ₹300 Cr |
What is the latest Profit & Loss Account Balance ratio of INDEGENE ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹1,478 Cr |
| Mar2024 | ₹1,073 Cr |
| Mar2023 | ₹736 Cr |
| Mar2022 | ₹469 Cr |
| Mar2021 | ₹300 Cr |
How is Profit & Loss Account Balance of INDEGENE Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,478 Cr | 37.77 | |
| Mar2024 | ₹1,073 Cr | 45.76 | |
| Mar2023 | ₹736 Cr | 56.90 | |
| Mar2022 | ₹469 Cr | 56.16 | |
| Mar2021 | ₹300 Cr | - | |
Compare Profit & Loss Account Balance of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹12,034.2 Cr | 1.7% | 10.5% | -12.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | 1.7% |
10.5% |
-12.7% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses